Cargando…
A Potential New Use for Tocilizumab: Refractory Checkpoint Inhibitor Hepatitis
Immune checkpoint inhibitors are becoming more commonly used for many forms of malignancy. With this class of medications being more heavily used, there has been an associated rise in medication-induced autoimmune hepatitis. This case involves a 35-year-old woman being treated with nivolumab/ipilimu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519460/ https://www.ncbi.nlm.nih.gov/pubmed/37753105 http://dx.doi.org/10.14309/crj.0000000000001162 |